BIO Begin Period Cash Flow from 2010 to 2025
| BKYI Stock | USD 1.01 0.04 4.12% |
Begin Period Cash Flow | First Reported 1997-03-31 | Previous Quarter 690.4 K | Current Value 1.3 M | Quarterly Volatility 3.2 M |
Check BIO Key financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BIO Key's main balance sheet or income statement drivers, such as Depreciation And Amortization of 573.1 K, Interest Expense of 186.6 K or Selling General Administrative of 5.1 M, as well as many indicators such as Price To Sales Ratio of 0.24, Dividend Yield of 0.0028 or PTB Ratio of 1.49. BIO financial statements analysis is a perfect complement when working with BIO Key Valuation or Volatility modules.
BIO | Begin Period Cash Flow |
Latest BIO Key's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of BIO Key International over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. BIO Key's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BIO Key's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
BIO Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 2,654,197 | |
| Geometric Mean | 684,223 | |
| Coefficient Of Variation | 163.36 | |
| Mean Deviation | 2,685,285 | |
| Median | 1,061,307 | |
| Standard Deviation | 4,336,006 | |
| Sample Variance | 18.8T | |
| Range | 17M | |
| R-Value | 0.39 | |
| Mean Square Error | 17.1T | |
| R-Squared | 0.15 | |
| Significance | 0.14 | |
| Slope | 355,123 | |
| Total Sum of Squares | 282T |
BIO Begin Period Cash Flow History
About BIO Key Financial Statements
Investors use fundamental indicators, such as BIO Key's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although BIO Key's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 3 M | 2 M |
Currently Active Assets on Macroaxis
When determining whether BIO Key International offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BIO Key's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Key International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Key International Stock:Check out the analysis of BIO Key Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share | Quarterly Revenue Growth (0.41) | Return On Assets | Return On Equity |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BIO Key's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.